| Dr Danny L Chang, MD | |
|
4929 Van Nuys Blvd, Sherman Oaks Hospital Emergency Department, Sherman Oaks, CA 91403-1702 | |
| (818) 907-4570 | |
| (818) 907-2814 |
| Full Name | Dr Danny L Chang |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 4929 Van Nuys Blvd, Sherman Oaks, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215981048 | NPI | - | NPPES |
| 00A861190 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A86119 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alhambra Hospital Medical Center | Alhambra, CA | Hospital |
| Garfield Medical Center | Monterey park, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gem Medical Group Corporation | 3072984400 | 51 |
| Shen Medical Group | 8527164482 | 23 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.
The U.S. Food and Drug Administration today finalized a new food safety rule under the landmark, bipartisan FDA Food Safety Modernization Act that will help to prevent wide-scale public health harm by requiring companies in the United States and abroad to take steps to prevent intentional adulteration of the food supply.
Biozoom exercised its option, under a joint venture agreement, to acquire 19.9% of Opsolution, a research and development company dedicated to advancing spectroscopic technology.
Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon's route to its desired destination in the brain. Their findings are described in the June issue of Nature Neuroscience.
› Verified 7 days ago
| Entity Name | Michael S. Agron, M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699716100 PECOS PAC ID: 2668360736 Enrollment ID: O20040707000788 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.
The U.S. Food and Drug Administration today finalized a new food safety rule under the landmark, bipartisan FDA Food Safety Modernization Act that will help to prevent wide-scale public health harm by requiring companies in the United States and abroad to take steps to prevent intentional adulteration of the food supply.
Biozoom exercised its option, under a joint venture agreement, to acquire 19.9% of Opsolution, a research and development company dedicated to advancing spectroscopic technology.
Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon's route to its desired destination in the brain. Their findings are described in the June issue of Nature Neuroscience.
› Verified 7 days ago
| Entity Name | Sherman Oaks Emergency Medical Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518904150 PECOS PAC ID: 1557377736 Enrollment ID: O20060224000406 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.
The U.S. Food and Drug Administration today finalized a new food safety rule under the landmark, bipartisan FDA Food Safety Modernization Act that will help to prevent wide-scale public health harm by requiring companies in the United States and abroad to take steps to prevent intentional adulteration of the food supply.
Biozoom exercised its option, under a joint venture agreement, to acquire 19.9% of Opsolution, a research and development company dedicated to advancing spectroscopic technology.
Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon's route to its desired destination in the brain. Their findings are described in the June issue of Nature Neuroscience.
› Verified 7 days ago
| Entity Name | Shen Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457427221 PECOS PAC ID: 8527164482 Enrollment ID: O20070509000575 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.
The U.S. Food and Drug Administration today finalized a new food safety rule under the landmark, bipartisan FDA Food Safety Modernization Act that will help to prevent wide-scale public health harm by requiring companies in the United States and abroad to take steps to prevent intentional adulteration of the food supply.
Biozoom exercised its option, under a joint venture agreement, to acquire 19.9% of Opsolution, a research and development company dedicated to advancing spectroscopic technology.
Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon's route to its desired destination in the brain. Their findings are described in the June issue of Nature Neuroscience.
› Verified 7 days ago
| Entity Name | Gem Medical Group Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689364721 PECOS PAC ID: 3072984400 Enrollment ID: O20230124000274 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.
The U.S. Food and Drug Administration today finalized a new food safety rule under the landmark, bipartisan FDA Food Safety Modernization Act that will help to prevent wide-scale public health harm by requiring companies in the United States and abroad to take steps to prevent intentional adulteration of the food supply.
Biozoom exercised its option, under a joint venture agreement, to acquire 19.9% of Opsolution, a research and development company dedicated to advancing spectroscopic technology.
Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon's route to its desired destination in the brain. Their findings are described in the June issue of Nature Neuroscience.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Danny L Chang, MD Po Box 662154, Arcadia, CA 91066-2154 Ph: (626) 447-0296 | Dr Danny L Chang, MD 4929 Van Nuys Blvd, Sherman Oaks Hospital Emergency Department, Sherman Oaks, CA 91403-1702 Ph: (818) 907-4570 |
News Archive
EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave" or "the Company") today announced that it has signed Confidentiality Agreements with more than 15 food production companies located in North and South America, Europe and Korea to determine the benefits of using its nutraREVTM food dehydration technology in a wide range of new product areas including herbs, mushrooms, bananas, mangos, pineapples, peppers, tomatoes, garlic, snack chips, shrimp, salmon and pet treats.
The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.
The U.S. Food and Drug Administration today finalized a new food safety rule under the landmark, bipartisan FDA Food Safety Modernization Act that will help to prevent wide-scale public health harm by requiring companies in the United States and abroad to take steps to prevent intentional adulteration of the food supply.
Biozoom exercised its option, under a joint venture agreement, to acquire 19.9% of Opsolution, a research and development company dedicated to advancing spectroscopic technology.
Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon's route to its desired destination in the brain. Their findings are described in the June issue of Nature Neuroscience.
› Verified 7 days ago
David I. Friend, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14916 Greenleaf St, Sherman Oaks, CA 91403 Phone: 818-212-0540 | |
Mr. Antoine Vernell Taylor Sr., NP Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4550 Van Nuys Blvd Ste A4, Sherman Oaks, CA 91403 Phone: 818-514-3631 Fax: 888-972-1912 | |
Keith Della Grotta, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4929 Van Nuys Blvd, Sherman Oaks, CA 91403 Phone: 818-907-2825 | |
Thomas Michael Reilly, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4929 Van Nuys Blvd, Sherman Oaks, CA 91403 Phone: 818-907-4570 Fax: 818-907-2814 | |
Dr. Dallas Edward Smith, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4929 Van Nuys Blvd, Sherman Oaks, CA 91403 Phone: 818-907-4570 Fax: 818-907-2814 | |
Dr. Jim Lai, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4929 Van Nuys Blvd, Sherman Oaks, CA 91403 Phone: 818-907-4570 Fax: 818-907-2814 |